Stockscreener 앱 받기
0.1748
3.43%
-0.0062
시간 외 거래:
.17
-0.0048
-2.75%
전일 마감가:
$0.181
열려 있는:
$0.1806
하루 거래량:
988.20K
Relative Volume:
0.23
시가총액:
$1.92M
수익:
-
순이익/손실:
$-7.35M
주가수익비율:
-0.38
EPS:
-0.46
순현금흐름:
$-5.48M
1주 성능:
+0.46%
1개월 성능:
-40.34%
6개월 성능:
-79.39%
1년 성능:
-67.08%
1일 변동 폭
$0.1717
$0.1869
1주일 범위
$0.1647
$0.1869
52주 변동 폭
$0.164
$3.30
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
명칭
Shuttle Pharmaceuticals Holdings Inc
전화
(240) 403-4212
주소
401 PROFESSIONAL DRIVE, GAITHERSBURG
SHPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
0.1748 | 1.91M | 0 | -7.35M | -5.48M | -0.46 |
|
HLN
Haleon Plc Adr
|
11.35 | 50.14B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
168.63 | 72.38B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.79 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.51B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.45B | 16.54B | -1.64B | 749.00M | -1.45 |
Shuttle Pharmaceuticals Holdings Inc 주식(SHPH)의 최신 뉴스
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Increase in Short Interest - Defense World
Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Johnson Matthey (LON:JMAT) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Shuttle Pharmaceuticals slashes exec salaries by 70% as it fights to preserve cash - The Business Journals
Shuttle Pharmaceuticals Holdings Implements 70% Salary Reduction For ExecutivesSEC Filing - marketscreener.com
Shuttle Pharmaceuticals Announces Major Salary Reductions - TipRanks
SHPH stock plunges to 52-week low of $0.2 amid market challenges - Investing.com India
Shuttle Pharma Provides Corporate Update - citybiz
Shuttle Pharmaceuticals Announces Leadership Changes and Meeting Outcomes - TipRanks
Shuttle Pharma Phase 2 Brain Cancer Trial Shows Promise: 84% Patient Completion Rate Signals Strong Progress - Stock Titan
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Certain Common Stock of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2025. - marketscreener.com
Certain Pre-Funded Warrants of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2025. - marketscreener.com
Shuttle Pharma’s glioblastoma trial reaches halfway mark By Investing.com - Investing.com Nigeria
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharma’s glioblastoma trial reaches halfway mark - Investing.com
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial - GlobeNewswire
Shuttle Pharmaceuticals Holdings Offers Up To 10,000,000 Shares Of Common Stock - marketscreener.com
Did Shuttle Pharmaceuticals Holdings Inc (SHPH) perform well in the last session? - uspostnews.com
Market Resilience: Shuttle Pharmaceuticals Holdings Inc (SHPH) Finishes Weak at 0.27, Down -8.74 - DWinneX
Nothing is Better Than Shuttle Pharmaceuticals Holdings Inc (SHPH) stock at the moment - Sete News
Shuttle Pharmaceuticals Holdings Inc [SHPH] moved up 0.12: Why It’s Important - dbtnews.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Small Cap Stock Shuttle Pharmaceuticals Holdings Inc (SHPH) Is A Buy – Analysts - Marketing Sentinel
The Psychology of Shuttle Pharmaceuticals Holdings Inc Inc. (SHPH) Price Performance: Understanding Market Sentiment - investchronicle.com
A review of SHPH’s current quarter earnings predictions - uspostnews.com
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - GlobeNewswire
Shuttle Pharma's Latest Glioblastoma Trial Data and Cancer Diagnostic Advances: Key Updates Coming April 23 - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World
SHPH stock plunges to 52-week low of $0.33 amid steep annual decline - Investing.com India
Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer - marketscreener.com
Shuttle Pharma files patent for cancer treatment innovation - Investing.com Australia
Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer - marketscreener.com
Shuttle Pharma Developing Pretreatment Diagnostic Blood - GlobeNewswire
Game-Changing Prostate Cancer Treatment: Shuttle Pharma Unveils Breakthrough PSMA Technology - Stock Titan
Head to Head Analysis: Shuttle Pharmaceuticals (NASDAQ:SHPH) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023 - Seeking Alpha
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Shuttle Pharmaceuticals Appoints New Interim CEO and CSO - TipRanks
Shuttle Pharmaceuticals signs consulting deal with Bowery Group By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals signs consulting deal with Bowery Group - Investing.com
Shuttle Pharmaceuticals Holdings IncOn March 21, Enters Consulting Agreement With Bowery ConsultingSEC Filing - Marketscreener.com
Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead - Asianet Newsable
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 3.8% – Should You Buy? - Defense World
Shuttle Pharmaceuticals Holdings Inc (SHPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
18.36%
0.52%
자본화:
|
볼륨(24시간):